66th Annual Meeting
November 5-9, 2017
Baltimore, Maryland, USA
DNDi will be presenting on Chagas disease.
by Giralt AN, Nöstlinger C, Lee J, Salami O, Lallemant M, Ouma O, Nyamongo I, Marchal B.
BMJ Open, March 2017
Reuters [21 April, 2017]
“Progress in fighting tropical diseases but funding and conflicts pose challenges”
Radio Okapi [20 April, 2017]
“RDC: des efforts sont nécessaires pour éliminer les maladies tropicales négligées” – “DRC: efforts needed to eliminate neglected tropical diseases”
Devex [20 April, 2017]
“Commitments made on neglected tropical diseases at WHO summit”
Le Temps [19 April, 2017]
“Des progrès dans la lutte contre les maladies tropicales négligées” – “Progress in addressing neglected tropical diseases”
Le Monde [19 April, 2017]
“Mobilisation contre les maladies tropicales négligées” – “Mobilization against neglected tropical diseases”
Devex [18 April, 2017]
“Strides in progress on neglected tropical diseases as global partners meet”
10th European Congress on Tropical Medicine and International Health
October 16-20, 2017
DNDi will be participating at the event.
Financial Times [18 April, 2017]
“The long road to elimination of neglected tropical diseases”
[Tokyo, Japan – March 30, 2017]
Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Daiichi Sankyo Company, Limited (hereafter, “Daiichi Sankyo”), announced that it has entered into a new joint research agreement with the Drugs for Neglected Diseases initiative (hereafter, “DNDi”) with regard to a new research program, the Hit-to-Lead Project, with the aim to develop drug treatments for two neglected tropical diseases, leishmaniasis and Chagas disease.
[Seattle, USA – February 14, 2017]
Landmark study proves that “super-boosting” approach counters negative interaction between key HIV and TB drugs
The non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis.
Ärzte Zeitung [30 January, 2017]
“London Declaration entfaltet ihre Wirkung” – “London Declaration develops its impact”
KEMRI Annual Scientific and Health Conference
February 8-10, 2017
Gina Ouattara, Project Coordinator for HIV/HCV, and Kevin Onyango, Project Coordinator for Mycetoma, both from the DNDi Africa office, presented at the event.
Our staff, partners, and stakeholders share their highlights from 2016.
WuXi App Tec [1 December, 2016]
“Harnessing science for the most neglected diseases – A chat with Charles Mowbray, Ph.D., Head of Drug Discovery, DNDi“
The implementation Project for Chagas disease in Colombia is moving forward. After an epidemiological analysis, the partners confirmed the change of the diagnostic algorithm for the country’s pilot projects. With the new algorithm, positive cases for Chagas are confirmed by a simpler procedure test.